Dr. Deborah Morosini is Executive Vice President and Chief of Clinical Affairs at Prelude Therapeutics. She previously served as Vice President of Clinical Affairs and Patient Engagement (Chief Patient Officer) at Loxo Oncology, and prior to Loxo, Dr. Morosini was Vice President of Clinical Development at Foundation Medicine.
Dr. Morosini has a particular passion for the genomics of adolescent and young adult (AYA) cancer. Inspired by her late sister and brother-in-law, Christopher and Dana Reeve, she has devoted her energies to raising awareness and research dollars for cancer research and early detection. She has been a featured spokesperson for numerous non-profit fundraising and government events in oncology and has provided expert commentary for national television and radio broadcasts, including NBC, ABC, CNN and FOX News.
Dr. Morosini received her MD from Boston University School of Medicine and completed a pathology residency at Boston Medical Center, where she was chief resident. She served on the NCI – DCLG board, and currently serves on the Board of Directors for the Lung Cancer Alliance, the National Comprehensive Cancer Network Foundation, the NPAF Scientific Advisory Board and the Cancer Support Community in Central New Jersey.